Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes

Bin-Yu Mo; Guo-Sheng Li; Su-Ning Huang; Zhu-Xin Wei; Ya-Si Su; Wen-Bin Dai; Lin Ruan

doi:10.12659/MSM.928185

26 December 2020 : Database Analysis

Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes

Bin-Yu Mo^1BCEF, Guo-Sheng Li^2BCEF, Su-Ning Huang^3DEF, Zhu-Xin Wei^2DEF, Ya-Si Su^4DEF, Wen-Bin Dai^4ADG, Lin Ruan^2ADEG*

DOI: 10.12659/MSM.928185

Med Sci Monit 2020; 26:e928185

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 9 Clinical significance of immune-related differentially expressed genes (IRDEGs) signature in laryngeal squamous cell carcinoma (LSCC). (A) Violin plot showing the difference in expression levels of 9 IRDEGs between LSCC samples (red violin) and control samples (blue violin), based on Wilcoxon test. (B–F) relationship between IRDEGs of signature and clinical parameters. “Grade” means neoplasm histologic grade. Age was in years.

Back to the Article

Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes

Your Privacy